StockBraker
$GDRX GoodRx launches Employer Direct GLP-1 weight-loss benefit offering
New offering lets employers choose eligible FDA-approved GLP-1 weight-loss drugs, set contribution levels, and optionally add GoodRx clinical care and fulfillment.
Program includes employer pricing made available by manufacturers for Wegovy, Wegovy HD, Wegovy pill, Foundayo and Zepbound KwikPen.
GoodRx said implementation can take as little as 30 days and positions the platform as a complement to traditional pharmacy benefits for drugs that may not otherwise be covered.
GoodRx is collaborating with Novo Nordisk (NVO) on employer pricing and serves as an approved independent program administrator for Lilly's employer program.
2
